Race in a Bottle Online

Author: Jonathan Kahn
Edition:
Binding: Hardcover
ISBN: 0231162987

Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age

At a ceremony announcing the completion of the first draft of the human genome in 2000, President Bill Clinton declared, "I believe one of the great truths to emerge from this triumphant expedition inside the human genome is that in genetic terms, all human beings, regardless of race, are more than 99. percent the same." Yet despite this declaration of unity, biomedical research has focused increasingly on mapping that.1 percent of difference, particularly as it relates to race.This trend is exemplified by the drug BiDil. Approved by the FDA in 2005 as the first drug with a race-specific indication on its label, BiDil was originally touted as a pathbreaking therapy to treat heart failure in black patients and help underserved populations. Upon clos author jonathan kahn format hardback language english publication year 04 01 2013 subject medicine subject 2 medicine general race in a bottle the story of bidil and racialized medicine in a postgenomic age jonathan kahn title 9780231162982 race in a bottle the story of bidil and racialized medicine in a isbn 10 0231162987 isbn 13 9780231162982 author jonathan kahn publisher columbia university press publication date 2013 01 04 format hardcover dimensions 229 x 158 x 31 mm weight 57 grams pages Read medical textbooks online like Race in a Bottle here

Race In A Bottle Ebook

Buy Race in a Bottle by Jonathan Kahn and Read this Book on Kobo's Free Apps. Discover Kobo's Vast Collection of Ebooks Today - Over 3 Million Titles, Including 2 Million Free Ones!

Race in a Bottle : The Story of Bidil and Racialized Medicine in a Post-Genomic Age, ISBN-13: 9780231162982, ISBN-10: 0231162987

Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age by Kahn, Jonathan [Hardcover]

Race in a Bottle Columbia University Press 9780231162982 09780231162982

Race in a Bottle Online

percent the same." Yet despite this declaration of unity, biomedical research has focused increasingly on mapping that.1 percent of difference, particularly as it relates to race.This trend is exemplified by the drug BiDil
Upon clos